However, although all samples in the exploratory cohort exhibited significant downregulation of this gene, only two tumours exhibited high levels of hypermethylation (521 and 840), suggesting additional mechanisms to explain CDKN1C downregulation in the remaining samples (Fig. 4). Here, CDKN1C is linked to neoplasm.